News|Articles|February 10, 2023
SCOPE 2023: Future Areas of Investment in Clinical Trials
Author(s)Andy Studna, Senior Editor
Advertisement
In an interview at the 2023 SCOPE conference with ACT editor, Andy Studna, Sunny Kumar, MD, partner at GSR Ventures speaks about how the clinical trials sector is evolving, specifically with increased investment in decentralized trials and recent technological advancements such as artificial intelligence and digital biomarkers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market
2
Real-Time Clinical Trials: What the FDA's Push Toward Continuous Oversight Means for Sponsors
3
ACT Brief: Real-Time Trial Infrastructure Gaps, Built-In Data Security, and AI-Enabled CDMO Value
4
Built-In, Not Bolted On: Why Clinical Data Security Has to Be a Design Principle
5